ESR1 and breast cancer: Studies have shown that 27-OH-Chol can bind the estrogen receptor (ER) and acts as an endogenous selective estrogen receptor modulator (SERM) with detrimental effects on breast cancer pathogenesis, acting as a partial agonist and promoting the growth of ER-positive cells [36,37,38,39].